Charité - Universitätsmedizin Berlin

New therapeutic approach to fight cancer discovered

Resting cancer cells can be selectively destroyed by inhibiting their energy metabolism. This is the recent discovery by researchers at Charité Universitätsmedizin Berlin and the Max Delbrück Center for ...

Sep 04, 2013
popularity 4.5 / 5 (2) | comments 0 | with audio podcast

Understanding inflammation

German scientists at Charité – Universitätsmedizin Berlin for he first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive ...

Oct 14, 2013
popularity 5 / 5 (1) | comments 0

Using computer models to predict more effective therapies

Scientist at Charité – Universitätsmedizin Berlin have used a computer simulation for predicting the effectiveness of various combination therapies for colon tumors. The study has been published in the current issue of ...

Jun 28, 2013
popularity 5 / 5 (1) | comments 0

A protein enables cardiovascular risk assessment

Researchers at the Charité – Universitätsmedizin Berlin have managed to predict the probability of a cardiovascular patient suffering a heart attack, stroke or arterial occlusion within three months. In the long-term, ...

Apr 04, 2013
popularity not rated yet | comments 0

A new promising approach in the therapy of pain

The treatment of inflammatory pain can be improved by endogenous opioid peptides acting directly in injured tissue. Scientists at the Charité – Universitätsmedizin Berlin and the Université Paris Descartes showed that ...

Dec 04, 2012
popularity 5 / 5 (2) | comments 0

Nanotechnology against pollen allergy

Scientists at the Charité – Universitätsmedizin Berlin have now been able to identify the grass pollen molecule, against which the allergic response of hay fever in children is initiated. In addition, it was shown that ...

Feb 11, 2013
popularity 5 / 5 (1) | comments 0

Using antibodies against immune deficiency

Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication ...

Sep 27, 2012
popularity not rated yet | comments 0